瀏覽海報時間

MP01-1: Immunotherapy with checkpoint inhibitors improves survival in patients with metastatic urothelial carcinoma

MP01-2: Inherited variants of adiponectin and its receptors are associated with the time to castration-resistant prostate cancer

MP01-3: Docetaxel rechallenge improves survival in patients with metastatic castration-resistant prostate cancer: A retrospective study

MP01-4: Management of adverse events in patients with metastatic renal cell carcinoma receiving second-line targeted therapy: Real-world experience in Taiwan

MP01-5: Combination of prostate health index with mpMRI for better assessment of true tumor boundary in prostate cancer

MP01-6: Perioperative and long-term oncological outcomes of patients with muscle invasive bladder cancer who underwent radical cystectomy: A single-center experience

MP01-7: The role of PD-L1 and Ki-67 in upper tract urothelial carcinoma

MP01-8: Combination of trans-perineal MRI– ultrasound fusion and template-guided mapping biopsy for prostate cancer diagnosis

MP01-9: Geriatric nutritional risk index as a prognostic marker for patients with metastatic castration resistant prostate cancer receiving docetaxel

MP01-10: Neoadjuvant immunotherapy as nivolumab and ipilimumab for muscle invasive urothelial bladder cancer: Preliminary report of single hospital